Q3 2024 Holdings
Filed 2024-11-07 | 38 holdings | $631.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $36.7M | 359,114 | 5.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $29.5M | 54,440 | 4.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $26.0M | 356,451 | 4.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $25.3M | 647,611 | 4.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $24.2M | 211,985 | 3.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $22.9M | 255,294 | 3.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $22.9M | 1,187,165 | 3.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $22.5M | 150,593 | 3.6% |
| Natera Inc(NTRA) | COM | 632307104 | $19.8M | 155,650 | 3.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $18.6M | 254,800 | 3.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $18.1M | 353,376 | 2.9% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $17.9M | 114,247 | 2.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $17.9M | 214,298 | 2.8% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $16.6M | 178,929 | 2.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $16.5M | 572,928 | 2.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $16.4M | 35,222 | 2.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $15.8M | 315,816 | 2.5% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $15.4M | 357,003 | 2.4% |
| Merus N V | COM | N5749R100 | $15.4M | 308,014 | 2.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $14.9M | 1,451,037 | 2.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $14.9M | 30,254 | 2.4% |
| Harrow Inc(HROW) | COM | 415858109 | $14.7M | 326,582 | 2.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $14.4M | 326,494 | 2.3% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $14.3M | 562,391 | 2.3% |
| Geron Corp(GERN) | COM | 374163103 | $14.2M | 3,124,967 | 2.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $13.7M | 535,092 | 2.2% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $13.3M | 664,985 | 2.1% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $13.2M | 947,878 | 2.1% |
| Repligen Corp(RGEN) | COM | 759916109 | $13.2M | 88,714 | 2.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.8M | 325,218 | 2.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $12.5M | 96,097 | 2.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $12.4M | 67,942 | 2.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $11.8M | 223,147 | 1.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $11.5M | 621,306 | 1.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $10.2M | 399,781 | 1.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $8.7M | 1,226,354 | 1.4% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $8.6M | 593,291 | 1.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.1M | 355,000 | 0.7% |